VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
-3.62%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$48.3M
AUM Growth
+$48.3M
(-18%)
Cap. Flow
-$121K
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$121K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
CRISPR Therapeutics
CRSP
$4.71B
| $20.3M | 41.93% | 498,558 | – | – |
|
|
GRTS
2
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $12.3M | 25.42% | 3,561,150 | – | – |
|
3
Passage Bio
PASG
$22.7M
| $6.84M | 14.16% | 4,959,769 | – | – |
|
|
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
| $3.41M | 7.05% | 543,753 | – | – |
|
5
Adverum Biotechnologies
ADVM
$64.6M
| $2.94M | 6.08% | 5,068,233 | – | – |
|
6
Aligos Therapeutics
ALGS
$73.3M
| $2.21M | 4.58% | 2,320,381 | – | – |
|
|
UTRS
7
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $374K | 0.77% | 1,673,700 | – | – |
|
|
CLVS
8
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – | -101,855 | Closed | -$121K |
|